You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ADI-PEG20

Showing 1 - 25 of 1,317
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Carcinoma Trial in Taoyuan (ADI-PEG20)

Recruiting
  • Hepatocellular Carcinoma
  • ADI-PEG20
  • Taoyuan, Taiwan
    Chang Gung Memorial Hospital, Linkou branch
Sep 6, 2023

Prostate Cancer Trial in Houston (ADI-PEG 20, Cabazitaxel, Carboplatin)

Not yet recruiting
  • Prostate Cancer
  • ADI-PEG 20
  • +2 more
  • Houston, Texas
    MD Anderson Cancer Center
Oct 16, 2023

Obesity, PreDiabetes Trial in Saint Louis (ADI-PEG20, Placebo)

Not yet recruiting
  • Obesity
  • PreDiabetes
  • ADI-PEG20
  • Placebo
  • Saint Louis, Missouri
    Washington University School of Medicine
Apr 24, 2023

Metastatic Hepatocellular Carcinoma Trial in Houston (Atezolizumab, Bevacizumab, ADI-PEG 20)

Not yet recruiting
  • Metastatic Hepatocellular Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Aug 24, 2023

Soft Tissue Sarcoma, Sts, Sarcoma,Soft Tissue Trial in Saint Louis (ADI PEG20, Ifosfamide, Radiotherapy)

Not yet recruiting
  • Soft Tissue Sarcoma
  • +2 more
  • ADI PEG20
  • +3 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Apr 2, 2023

Soft Tissue Sarcoma Trial (ADI PEG20, Placebo)

Not yet recruiting
  • Soft Tissue Sarcoma
  • ADI PEG20
  • Placebo
  • (no location specified)
Jan 31, 2023

Nonalcoholic Steatohepatitis (NASH) Trial in Taiwan (ADI-PEG20, Placebo)

Not yet recruiting
  • Nonalcoholic Steatohepatitis (NASH)
  • ADI-PEG20
  • Placebo
  • Kaohsiung, Taiwan
  • +4 more
Apr 24, 2023

Glioblastoma Multiforme (GBM) Trial in Taoyuan (ADI-PEG20, Temozolomide)

Recruiting
  • Glioblastoma Multiforme (GBM)
  • Taoyuan, Taiwan
    Chang Gung Memorial Hospital, Linkou Branch
Sep 29, 2022

Acute Myeloid Leukemia, Adult Trial in Houston (ADI-PEG 20)

Recruiting
  • Acute Myeloid Leukemia, Adult
  • ADI-PEG 20
  • Houston, Texas
    MD Anderson Cancer Center
Sep 29, 2022

Metastatic Melanoma, Skin Cancer, Tumor Trial in New York (ADI PEG 20)

Completed
Has Results
  • Metastatic Melanoma
  • +2 more
  • ADI PEG 20
  • New York, New York
  • +1 more
Oct 3, 2022

Non Small Cell Lung Cancer, NSCLC, Small-cell Lung Cancer Trial in Saint Louis (ADI-PEG 20, Gemcitabine, Docetaxel)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • ADI-PEG 20
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 14, 2022

Advanced Solid Cancers Trial in Tainan (ADI PEG20, Pembrolizumab)

Terminated
  • Advanced Solid Cancers
  • Tainan, Taiwan
    Facility National Cheng Kung University
Apr 20, 2022

Resectable Hepatocellular Carcinoma Trial in Houston (Nivolumab, Pegargiminase, Resection)

Recruiting
  • Resectable Hepatocellular Carcinoma
  • Nivolumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 10, 2022

Hepatocellular Carcinoma, Advanced Hepatocellular Carcinoma Trial in Taiwan (ADI-PEG20, Placebo)

Recruiting
  • Hepatocellular Carcinoma
  • Advanced Hepatocellular Carcinoma
  • ADI-PEG20
  • Placebo
  • Changhua, Taiwan
  • +8 more
Oct 19, 2022

Small Cell Lung Cancer Trial in Worldwide (ADI-PEG 20 (Arginine deiminase pegylated))

Terminated
Has Results
  • Small Cell Lung Cancer
  • ADI-PEG 20 (Arginine deiminase pegylated)
  • New York, New York
  • +7 more
Oct 3, 2022

Uveal Melanoma Trial in New York (ADI PEG20, Nivolumab, Ipilimumab)

Active, not recruiting
  • Uveal Melanoma
  • ADI PEG20
  • +2 more
  • New York, New York
    Memorial Sloan - Kettering Cancer Center
Jan 10, 2022

Advanced Gastrointestinal (GI) Malignancies, Hepatocellular Carcinoma, Gastric Cancer Trial in Worldwide (ADI-PEG 20 plus

Terminated
  • Advanced Gastrointestinal (GI) Malignancies
  • +3 more
  • ADI-PEG 20 plus modified FOLFOX6
  • San Francisco, California
  • +34 more
Apr 18, 2022

Mesothelioma Trial in Worldwide (ADI-PEG 20 plus Pem Cis, Placebo plus Pem Cis)

Completed
  • Mesothelioma
  • ADI-PEG 20 plus Pem Cis
  • Placebo plus Pem Cis
  • Phoenix, Arizona
  • +44 more
Sep 30, 2022

Advanced Pancreatic Cancer Trial in New York (ADI-PEG 20)

Completed
  • Advanced Pancreatic Cancer
  • ADI-PEG 20
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Sep 30, 2020

Acute Myeloid Leukemia Trial in Taiwan, United States (ADI-PEG 20)

Completed
  • Acute Myeloid Leukemia
  • ADI-PEG 20
  • Houston, Texas
  • +5 more
Sep 24, 2020

Pleural Mesothelioma Malignant Advanced, Peritoneal Mesothelioma Malignant Advanced, Non-squamous Non-small Cell Lung Carcinoma

Terminated
  • Pleural Mesothelioma Malignant Advanced
  • +6 more
  • ADI-PEG 20
  • Rochester, Minnesota
  • +3 more
Sep 24, 2020

NSCLC Trial (Atezolizumab, Pemetrexed, Carboplatin)

Withdrawn
  • Carcinoma, Non-Small-Cell Lung
  • (no location specified)
Feb 24, 2020

Acute Myeloid Leukemia Trial in Kaohsiung, Tainan, Taoyuan (ADI-PEG 20, Cytarabine)

Terminated
  • Acute Myeloid Leukemia
  • Kaohsiung, Taiwan
  • +2 more
Mar 3, 2020

Lymphoma, Follicular, Lymphoma, Mantle-Cell, Marginal Zone Lymphoma Trial in United States (ADI-001, Fludarabine,

Recruiting
  • Lymphoma, Follicular
  • +5 more
  • ADI-001
  • +2 more
  • Stanford, California
  • +6 more
Oct 19, 2022

Pain, Postoperative Trial in Taipei City (Naldebain, SafeTynadol, Naldebain + SafeTynadol)

Not yet recruiting
  • Pain, Postoperative
  • Taipei City, Beitou District, Taiwan
    Taipei Veterans General Hospital
May 3, 2023